Projects
![]()
No projects found
Investors
New
DAO Treasuries
DATs
Lend / Borrow APRs
Chains
Categories
Spaces
DeSci what did you get done this week? #6
Recorded: March 28, 2025 Duration: 1:02:06Space Recording
Short Summary
This week's Desai mic session highlighted significant project launches, strategic partnerships, and innovative fundraising efforts within the crypto ecosystem, showcasing a vibrant community dedicated to advancing decentralized science and health initiatives.
Full Transcription
Thank you. Thank you. Thank you. Thank you. All right, all right. Welcome back to the Desai mic this week, or is number six of Desai Mike this week or is number six of Desai What Did You Get Done This Week.
Super excited to hear updates from different projects on the latest of what's happening within their ecosystem, within their world,
and also what to look forward to coming up in the near future, either from an event perspective or if you're launching a token, some new product
that people can be engaging with, all of that is welcome to share. I just shared up to the top or
pinned it up above, the Desai event calendar has a few events listed on that. There's one in San Francisco tonight at the Avidas house.
So if you're in the Bay Area, definitely come through there. Should be a great hangout of a lot
of cool people in the Desai space and adjacently connected, just looking through the list there.
and Adjacently Connected, just looking through the list there. Also on Sunday, there is an event
down in LA, and that one will be at the Quantum Biology Lab and Institute space. So super inspiring,
awesome location, have a few really cool speakers lined up there, and hackathon type vibes going on at that event. So those are a few coming up
in the next couple days. And then next kind of big event to have on your radar is Desai London,
which takes place on April 12th and 13th. If you haven't made plans yet to be in London during that time, would highly
recommend it. Line up there is shaping up to be really, really incredible and will be a great
balance of different talks mixed with some unconference time as well to connect and build
out some of those collaborations and foundations to really take all of these
projects to that next level.
So those are a couple different events that I'm excited about happening in the near future.
This calendar is also open.
So if you know of any other events, if you're hosting an event, if your friend is hosting
an event, or if you're just excited to attend an event and it has even a panel on DSI within it, this Luma calendar is open.
So you can submit events directly to it and it goes out to a whole list of people who want to
be updated on upcoming DSI events. So even if you have something kind of scheduled out tentatively for way later in the year,
feel free to submit that as a TBD and that can get on people's radars so they can start
planning for it.
I guess those are the main event housekeeping updates I have right now.
Would love for anyone listening in to request the mic.
This space is time for you to share those different project updates as well as those upcoming events.
So just request the mic. Come on up here.
I come on up here.
This can also be a space for us to talk about different things that are top of mind for
us in the DSI space or that's connected to that.
I know there's been a few announcements through the White House recently that might be top
of mind too.
So it can also evolve into a broader discussion of what's top of mind in DSI right now.
With that said, Poseidon Dow, welcome up here.
Great to see you. I know you've had some cool updates shared recently, especially with Rare
Compute. Renee, see you down in the audience. So, we'd love to hear an overview on that,
hear an overview on that as well as anything else top of mind for you guys.
as well as anything else top of mind for you guys.
Hi Aaron, Marco here. Great to be here once more. Indeed, we have done some important stuff for
the DAO this week, including the proposal for Rare Compute. They have some groundbreaking research they want to kickstart.
And in a couple of days, we will indeed find out if that will be the case.
We did get a lot of positive comments from our community members.
And yeah, so looking forward to the results.
But yeah, it's very important that all of this is happening through our platform.
Everything's on-chain, transparent and, well, to some degree decentralized.
Of course, we would like to grow our participants over time.
But we're really happy with the turnout so far.
Yeah, maybe Renee can also tell a little bit
about her experience so far.
But yeah, it's been a very important week
for Poseidon DAO, for sure.
for Poseidon DAO, for sure.
Amazing, amazing.
It's so cool to see that progress posted out there
and then having that community vote be part of it as well.
René, welcome.
Yeah, hi.
Hey, Aaron.
Hi, Marco.
Hello, everybody.
Super excited to be here and always happy to hop on a design mic when I got the time.
Wow, what a freaking exciting week it's been for me.
The Rare Compute Foundation has just been all hands on deck from an operations standpoint,
really kind of gearing up under the assumption this proposal is going to pass.
We want to make sure we're ahead of the game.
So I've got my project management hat on this week.
I've got my GitHub operations hat on this week.
And it's just been a very good experience so far
and super excited to see the turnout.
I think we've got over, what is it, $300-something
thousand locked worth of Cosign and Dow tokens, so that's pretty cool to see the community show
up for that. And yeah, just really thankful to be here. I guess this is like a tactical
what-did-you-get-done call, so I'm going to show off a little bit because I've had a very busy week. So what did I get done this last week? I put together a budget for a three-month project
and submitted it on chain to the first ever DAO governance proposal process, Poseidon DAO.
I submitted a form. This is not that exciting, but it's actually a lot of work. If you're
familiar with form 1023, it is a very long form that
nonprofits have to file in the US to get their 501c3 application. So I've been working on that
and doing some like legal operations compliance stuff. Also been working on a new side project
where I deployed my own personal website on Fleek and IPFS, which I will release
probably next week sometime. But but yeah it's been a
busy week for me i've gotten a lot done i'm super pumped up i know poseidon dow is super excited
we've been meeting uh weekly with them for what feels like months now and uh we'll continue to do
that continue to update everybody um yeah it's gonna be full steam ahead. I've got Stanley sort of focused
on the science side of things, and I'm just trying to keep him unblocked and ensure we can really
kind of show the world what we can do with, you know, just a little bit of capital.
Definitely. It's so cool how much can be done with just a little bit of intentional effort,
aligned effort, that collaboration, and the capital infusion to really accelerate that
and make that move forward. Would highly recommend for anyone that hasn't yet checked out this
proposal to go, I think it's probably towards the top of the feed on Poseidon DAO's page,
as well as either Rare Compute, possibly on Renee's page as well.
You guys can confirm to be able to best find that link,
or if we can get that pinned up above, that'd be great too.
Yeah, super, super excited for this and for this foundation to be laid just for other DAOs and organizations kind of follow suit in this on-chain voting type of approach as we're building all these projects forward. to more the proposal part of it or some of that engagement with the broader community.
I think there's a lot other projects can be learning.
So happy to have you both elaborate.
Yeah, I mean, I'm happy to talk a little bit more about the proposal, maybe for those who missed the AMA we did with the CITENDAO.
Yeah, I think it was yesterday.
The proposal is a relatively complex proposal, if I'm being honest.
I am a social scientist, data scientist, you know, went through a PhD program, and I find some of the material to be dense.
So I understand if there's people in the audience that, you know, maybe are still kind of hoping for a more simple explanation.
So let me let me try to do that.
So basically, what we're doing is really cool, because we're at the intersection of biology,
machine learning, decentralized science, and decentralized physical infrastructure networks,
or DEPIN. And what we're proposing to do is to be, if you're familiar with generative AI,
we're proposing to develop sort of what we like to call the mid-journey for molecules,
where we want to prove that we can reduce the time to drug discovery by years
by years by using these generative AI tools.
by using these generative AI tools.
And we scoped this initial project for a three-month time horizon.
And during that three-month time horizon, we're going to be setting up a very complex machine learning system
that's using, you know, dozens of open-source models sort of weaved together to get this all communicating. We have sort of a world-class molecular engineer
who's supporting this project.
Her name is Amelie.
And Amelie and Stanley are sort of leading
the science side of things.
And I'm going to be sort of driving the operations
side of things.
And we're really hoping to walk away with molecules
that can be taken to a wet lab.
And this is a term that I'm still kind of getting used
to throwing around, but when I say wet lab,
I just mean where there's actual biological specimens
being used and it's not purely computational, right?
So the dry lab phase of the experiment,
which is the first three months that rare compute is sort of owning and driving
is what they call a dry lab experiment and you can basically think of that as it's a simulation
it's a giant simulation where we're simulating new molecules looking for different targets that
might you know be successful in a wet lab setting um So that's like the whole proposal is like trying to get
that architecture set up.
And then the second part of that proposal
is developing what's called a wet active,
a dry active learning loop.
And what this is, is basically traditional science
and how it goes about drug discovery right now is very linear.
And there's a lot of handoff processes
and there's not a lot of iteration that goes into it,
which is a big reason why so much of drug discovery fails.
You know, it's got such a low success rate.
And so we want to prove that we can have a super high success rate.
And the wet lab partner we're working with actually has about a 50%, 60% success rate on working with fly models.
And what's really interesting here is, like, they're actually trying to embed, you know, human DNA and, like,
here is like they're actually trying to embed you know human DNA and like these
human molecules into into flies into fly systems to better understand the
biology of it so they have like around a 60% success rate of doing that and this
is with the Baylor Medical so that's kind of like a high level sort of what
the next three months looks like and And what's cool about the feedback loop is once we get the data to the wet lab, and they start experimenting, we can then use the data they produce to feed it back into our generative AI system. And that's where the feedback loop comes from.
loop comes from. So it's a pretty, it's a pretty complex system, but I'm very excited. I think,
you know, one of the big things we're going to be looking for over the next few months is
to be telling good stories about it, because I think I don't want the silence to get lost.
But I don't, I need it to be clear that like what we're doing is very novel. It's very hard
and it's very cutting edge. So it's going to have some risk, but I think, you know,
I'm scoping risk pretty tight and we have several mitigation plans in place already with backup
academic partners. We have multiple compute partners. We have multiple scientific volunteers.
One of the critiques I saw us get from sort of wider D-Sci was actually we were
proposing that we could do too much with too little. And I respect that comment. I think
what's sort of failing to be noticed through the proposal is that there's actually a huge
volunteer workforce and sort of volunteer network of partnerships that are making this
possible. Like this is a very big project. Dell Computer Alliance is working with us and providing,
you know, hundreds of thousands of dollars worth of compute, I'm sure, if we put it on paper.
We have another compute partner with a D-Pen project called Kinesis that's, you know, providing their service
for free. Stanley has multiple scientists volunteering their time on this. Like it's
going to take a whole village to make this project happen. And I'm just so thankful for Poseidon Dow,
you know, providing that initial seed funding to have a proof of concept. But I think it is,
it also would be dishonest to say
we're going to pull this off for nothing but $150K
because that's not true.
There's hundreds of thousands of dollars of resources
going into this project right now.
Amazing.
I think some of that context really helps people feel grounded
in some of these amazing initiatives
and encourage that it's actually going to be
pulled off successfully. And knowing all the people involved so far, I'm so excited for
what's to come here. And I think it'll be really awesome. So thanks for providing some of that additional context of those other partners involved too.
I think as DSI keeps moving forward, we'll see more and more collaborations like that and different proposals being like one element to making some of this advancement in DSI and in science really possible.
And this more holistic type of approach being what's needed
to take it forward. Set in doubt, welcome back up here if you have any other thoughts to add as well.
Yeah, I think René put it quite well and very well actually. It's indeed a large project but the whole idea and also what what
Stanley and Renee have mentioned when we talked to them before is that the idea with DCI and
leveraging artificial intelligence the whole idea is that we can use that to cut down the costs. So although we, as I said, we do understand that there's some
skepticism with just the 115k, but the, yeah, I think it follows perfectly the DSI ethos.
It has to be, you know, you get the funding quickly. At the end of the week, the proposal voting phase is over. Then we have a three-day
delay before we can execute the transaction from our treasury. So sending the money from
our treasury to the Rare Compute Foundation on-chain. That transaction, yeah, so the delay is there to facilitate any other legal aspect
that we need to cover or any other preparations we need to have in order to facilitate this
transaction.
So within, let's say, 11 days, 10, 11 days, we can have the funds to the researchers.
And if we compare that to, let's say, an NIH grant where it takes 8 to 20 months, we are
Definitely improving in terms of speed.
definitely improving in terms of speed.
Of course, we're not taking into account where, you know, we have
received several projects already and some did not make the selection.
Of course, there's some selection procedure that takes time.
But all in all, if you fit the criteria within 11 days,
you could have your funds.
So that is definitely important.
In addition, what else we did this week?
So I'm crossing the T's and dotting the I's on the white paper
for one of the in-house projects that the DAO has,
which is called WeCura. It is a predictive machine learning model for drug response in
a couple of cancers that we are very interested in. So you can read all about that later tonight or tomorrow,
depending on how fast I can finish this up.
And yeah, with that being said, we will be opening up the project submission process through our website.
So then other scientists can submit their projects, will get reviewed as soon as possible,
and then put as a proposal on-chain.
So then the community can have a say if our treasury should be dedicated,
or a portion of the treasury should be dedicated to those research projects.
So, yeah, hopefully with that we can
really unlock scientists, give the scientists the ability to get money fast, do what they love to do
without any political issues from our side or influences, just decentralized governance.
And, yeah, so that's something we will,
that project submission process will be published soon,
most likely next week on Monday.
But, yeah, that's what we've been working on this week.
Amazing.
Those are super cool updates to be sharing of what you're working on this week.
And I'm sure elements of it have been in conversation or building up to this for a while. So excited to see what comes through from the voting and getting kind of things going
for the researchers to be able to keep pushing forward. So super exciting updates.
Rene, did you have any other additions on to what he was sharing?
uh nothing rare compute or poseidon dow related uh erin i know you and i have talked a little bit
about this behind closed doors and i don't think i'm quite ready to to mention it um on a space
but i am like i've got some other things i'm working on i'm very excited about so maybe future
spaces will tease them out yes uh can confirm for anyone listening in,
if you aren't yet following Renee, go follow Renee. Really cool things, uh, being announced
probably in the near future, um, that I think could really help advance Desai forward in
a really necessary type of way.
So go follow her if you are not already.
That's all I'll say for now.
On that note, let's jump over to Desai Asia.
Welcome up to the stage.
Would love to hear what's happening within your world
and ecosystem this week.
Hello, everyone.
GMGM, and good evening.
So here's some updates from Asian PACT.
And first of the update here I would like to share with you
is that recently we collaborate with different kinds
of Asian community and the platform. And one of that is the first Asian grant for design,
which we collaborate with the Design Asia
and also the Fund Design Platform,
and also Design India, Design Tokyo,
and also Hippograph,
which is the digital health platform based on Seoul.
So therefore we announced the results
and allocate the funding or the grants
to the top three project,
which is focusing in design development in Asia.
So we have to look at that one.
And field fund design is one of the crowdfunding platform,
which is based in mid-Asia.
So therefore we hope to support the which is a very localized platform developed from the bottom up
comparing with different kinds of big organizations out there.
But that is the one platform which is based in Asia. So this is the first update right there.
based in Asian so this is the first update right there and another another
one is that because the build up of design Indonesia so of course that
real real few update right there but because we got we got them just set up their Twitter
and they set up a sub channel in Design Asia
Telegram groups to get more and more people from Indonesia
before they got any upcoming event or ideas come up.
We just have them, which is born in this month.
And this is the second one from Design Indonesia.
And the third one, which comes from another DAO
called CancerDAO, maybe a lot of you already heard about it.
And they are building and they just finished
their first in real life meeting and in Shanghai and this is the real amazing
doubt which is most of them of course from from China but of course there are
different kinds of contributor and and and targeting about the cancer topic from them.
So they just completed their first in real life meeting
happening in Shanghai last month.
And then they will come in, they just finished another AMA
collaborate with Noble Block and other contributors from different kinds of design
platforms over there just yesterday. So if you have looked about if you're interested about
the cancer developments, there will be cancer doubts happening right there. And another news Another news comes from DesignSolve. So after recently, regularly we have the social networking
with Tokyo, pro-Canada,
so right there collaborate with of course DesignAsia.
So we got an AMA for the social networking
and doing that social networking,
we heard that DesignSolve may have a planning
for international or maybe
a symposium happening coming in September.
So if you are interested or have a plan to go to Korea in the late of this year, so maybe
try to keep follow up about their twitter and i just share about their after meeting video which
is happening last year because last year they host a very successful international event of
design tokyo 2024 they make an after events video so you you will have a summary or catch up about
what they are doing last year so uh in this year, they are planning something in September.
So if you are going to Asia, don't forget
to follow up their Twitter to have a look at that one.
And then, may I talk too much?
No, these are great updates.
Do you have a link to some of that stuff in September?
Or is that something to be on the lookout for?
Oh, yeah.
That just mentioned about the planning,
but there is not a concrete link or notion or rumor
at this moment during our social networking AMA last month.
So therefore, the best way is just to follow their Twitter.
Once they got some confirmation details right there,
they will surely they will post up on their design
software Twitter to invite everyone to join.
So there is a hash up for everyone to know about what they are planning
at this moment. And then of course for Dissent Asia is coming and this Sunday we have we invite
another project called GenPlus which is based in Singapore. We have the founders to share with us, Fiona,
to share with us what is Dream Plus AI,
which is the AI collaborate with the hair care
and the dermatology right there.
So we will have sharing platforms
to different kinds of project and community monthly.
So this time we have one which is focusing for the hair care so if you
would like to have a look about that one and give you to join on this sunday and the last one would
be the uh ens and octane uh qf run yes we are participated in this round at this moment. So feel free to support us because, for example, the event we mentioned before,
and we utilize different kinds of QF round funding to support the in-real-life meeting
retrospectively and also support Design Asia development for different kinds of projects.
Yep, that's all. and also supports Design Asia development for different kinds of projects right there.
Yep, that's all.
AMANDA WONG- Amazing.
So much cool stuff to be checking out.
Even though we've just covered three different projects
or speakers, so many cool things happening
and opportunities to be able to get involved.
Thank you for sharing all those different updates and opportunities to be able to get involved.
Thank you for sharing all those different updates
and lots more exciting things to be on the lookout for.
Ed, we'd love to pass it over to you,
hear about what you got done this week,
any upcoming events for us all to keep on our radars as well,
or other opportunities to engage with things
you're building and working on.
Welcome. Yeah, thanks, Aaron. Yeah, we had a podcast this week on my scrops, my cost,
working with a microscope. I have a hard time pronouncing that microscopy.
Anyway, and we've learned that we can, through illumination, the right light sources,
instead of just a compound microscope, be able to identify beneficial fungi. And we're starting to
learn how some of these organisms, actually the epigenetics involved with them, which is really
some fascinating stuff.
But one of the things I've been pondering the last week and probably will be for the next week or so as activity has stepped up in the DSI movement is so much of it's involved with sick care
and solving diseases and drugs and so little of it is involved in healthcare
and what we're ingesting
and our environmental and food epigenetics
and the chemicals in our system
and the why of why we have so many diseases
and why there's so much work has to be done on sick care because
of that. And I guess I'm feeling kind of lonely in that. And I don't know how to move forward
with that. It just always seems to be, a you know we need to discover a new drug because
we have a new problem and why do we have all these new problems that's you know what we've
been that's what the paradigm shift that we needed to create in agriculture was because
we realized that we were just looking at the wrong thing. We were doing the sick care.
We were, oh, we're going to have pathogens, so we got to kill them.
We're going to have weeds, so we got to kill them.
We have insects, so we got to kill them. And then we just got to feed our plant.
And, you know, we realized that was the wrong,
we were going completely in the wrong direction.
Not that we don't need to solve disease and sick that people
have, but I think we need to shut off the why are we getting all these things, you know, especially
when I work so many young people. That's, you know, being an old guy now, I know what I've gone
through and what so many of my friends that have passed away in the farm agricultural community because of what
they've been exposed to or so many people I know at a later age you know their health conditions
because of the food we've eaten and what's in our food and the lack of nutrients in our food and all
those sort of things and working with young people that's the biggest fear I have how do we stop them from getting these diseases and
and that's you know it's the we need we've got a sick care system that we pay 4.7 trillion dollars
in the United States for and we've got almost nothing for a health care system doctors aren't
even you know when they go to school they don't even learn about health.
They just learn how to, you know, somebody comes in, they've got this, they've got that.
They got a list of pills they can give them.
You know, try this.
If it doesn't work, call me back in two weeks.
And then there's side effects and blah, blah, blah.
blah, blah, blah, blah, and it goes on and on. And it's like, I just, before I, you know,
And it goes on and on.
expire myself and being an older age now, it's like, can we get onto the health? I mean, can
some people work on that? And I think because the more you understand, I mean, the more I've
learned about health, the more it helps me to understand disease and how to solve diseases. We found so many people
that have gone through the medical system and they've got this and they've got that and they've
tried this pill and they've tried that and then they get a side effect and whatever. And we're
just like, well, what we could do is we could try to offer you some nutrient-dense real food and give that a try.
You know, it can't hurt.
And all of a sudden, we're solving a lot of these things.
They're like, well, I've tried everything and this is actually working.
And so, and we realize if that'll work, that'll prevent.
And that's what I, that's my biggest concern is how do we prevent, especially with our kids, younger and younger, sicker and sicker on pills, on having psychological problems, having depression problems at such a young age.
It's just to realize people going to medical school
are on all these antidepressants and everything now.
It's like, what is going on?
And so I guess that's my part rant and part plea is,
you know, anybody who's interested in health,
I'm all ears and please connect to me
because I think that that's a group we need to get together,
you know, that looks at healthcare, not just sick care. They're both important and they both go
hand in hand, but it's lopsided at this point and, and it frustrates me. So I'll end it there.
I'll land it there.
Definitely agree on all these fronts of just kind of the frustration as well as the opportunity to connect some of these different dots to really have a transformative impact on people's health and how much opportunity there is to have that impact.
have that impact and that some of these different collaborations as well as education into those
spaces, just how much is still kind of a wide open domain to bridge some of those dots.
Been having some conversations with different doctors recently who have expressed a really strong interest in being connected earlier on in the
process to different science or health tech, medical tech related startups, and that they
would love to be able to either contribute different feedback of, hey, actually tracking
this other metric or variable would have a way greater impact for them
to provide better care, give them the data to be able to effectively make better decisions that
right now they just aren't having access to some of that different, whether it's health tracking,
wearable data, behavioral data, different things like that. So I think there
is an appetite, but just some of that like coordination element of it is still needed
to actually realize some of these desires on both sides of the equation. And I think many of us in
the DSI space or building out some of these different projects are coming from
this kind of personal perspective as well of seeing these different opportunities. I know
that's a good part of my journey or kind of motivation of being within this ecosystem as
well is how can we actually be impacting people's lives, especially if there are different
incentives in medicine or in research, kind of pushing back the other direction against,
especially like nutritional intake and how impactful that can be on our health.
So very much resonate with a lot of what you were saying, Ed.
very much resonate with a lot of what you were saying, Ed. Are there any different things that
you're seeing right now that are encouraging or hopeful or you're watching to see where those
projects or people might or initiatives might be heading in the future? Anything kind of on that
side of things for us to be checking out as well or or is that kind of a
task for us to maybe compile and look into over the next week no we're working on really i guess
i'd say it two fronts one is you know there's always the question of the synthetic chemicals
that are used in agriculture and there's thousands of them.
And then there's all the adjutants that are put into and their relations to health.
And so we've learned how we can farm without any of that stuff, because for many years, I mean, that's where this movement started many years ago, you know, we started using all these chemicals. And when you had a family with children come to buy your produce and they're like, and
they started to hear back going back to Silent Spring by Rachel Carson's with DDT and stuff.
We started getting questions like, you know, these chemicals are you're using, are they
safe?
And, and all we could say is, well, they tell us they're safe.
But, you know, when you're handing over that food to a family with children, you think about that.
So, and of course, the Chem Ag, you know, they keep saying, oh, no, it's all safe and effective, all that stuff.
And yet, we got all these problems coming.
So what we're doing is our best idea is if we don't need it, why use it? Then there's no question. On the other front is why is our food doesn't taste like anything? And if it doesn't taste like anything, because that's a natural instinct of taste for what you should be eating, then it wasn't, we had to, we came up, actually, it was the regenerative ag movement that came up with the concept of, is there something to nutrient density?
And I was on a podcast with one of the most outspoken biotech, chem ag researchers at a university.
He speaks all over.
He's got his own podcast and everything.
And, you know, when he talked about, he was asked, does this nutrient density thing mean anything?
And he said, no, no, from all the research I hear, it's not really a factor by how it's grown and everything. Well, that's, we've done the research because nobody would do it.
And it started out with the concept from a farmer, is there something, you know, he actually put out the term nutrient density.
And then is it something real?
And so we've been, we, when I mean in regenerative ag, we're like DESAI.
We're a decentralized farmer-driven movement that has attracted scientists.
And so we finally did the research and we tested lots of fruits and vegetables. And, you know, with some of the, like carrots, for example,
in the initial study was over 300 different carrots from grown all different conditions
submitted by all different people with all kinds of information, soil samples, practices,
varieties, locations, all these things. Because first we had to determine, is there something to
nutrient density? And we were shocked. We knew there was going to be some difference.
We were shocked to realize the huge difference and that 90-something percent of the food that
we have access to, the average consumer has access to, when we look at the spectrum,
is around 10 to the 25th percentile of what it could be. And we found out the number one
factor that was causing that or causing high nutrient density was a real healthy soil biome.
And of course, that's what we've destroyed in agriculture. So we realize we're really eating, you know, hollow foods. Or when we say our kids
won't eat fruits and vegetables, we go to the supermarket, we shop on the outside of the aisles,
you know, where the fruits and vegetables, the sort of whole foods are, but our kids won't eat
them. Well, when we test that stuff, and it's down at the 10th percentile for a kid,
that's natural instinct.
You know, they work by taste, just like all animals,
just like us do in the natural environment.
But when we give kids something that we test that is high nutrient density,
it has flavor, and kids love it.
And so, you know, that difference is tremendous.
In fact, we had a really interesting situation.
We had a researcher that worked for, I think it was 38 years in the chem ag industry,
developing fungicides. And, you know, he worked
his way up and major developer of fungicides for, you know, some of the biggest pesticide companies.
And he got near retirement and decided, you know, maybe I'll retire a little bit early. I've kind
of wanted to farm, have a gentleman's farm and stuff.
And he started to hear about regenerative agriculture.
And he started to, you know, he was a really good researcher.
He learned how to do scientific method, how to do field trials,
all that sort of thing.
And since we're not in a lot of the academic journals
and everything that he had access to,
he realized all these guys are on podcasts and YouTube.
And for his last year, his story is for his like last year, year and a half, he was working at a field station and he had about an hour and a half drive each way to go to work and back every day.
drive each way to go to work and back every day. So he says, I had a pad next to me with a pen,
and every day to and back, I would listen to these podcasts, and I'd write down what I was learning.
So then he started a citrus farm, planted 1,300 plants, decided to do it really scientifically,
laid out plots and all this sort of thing
started to incorporate what he had learned in these practices and he also did a commercial
little area so he used the typical pesticides herbicides for synthetic fertilizers and
everything did all that work and but then he had to eventually eliminate that because he wanted to be organic
certified because he wanted to really work completely with nature so but then what he had
to do is he had to find a neighbor in his area that did everything the way they were told to do
it with all the chemicals all the pesticides and everything was even growing the same varieties of grapefruit and orange that he was growing so that he could do comparison studies.
So he got his first crop this last year and he sent the samples in.
He got samples, same variety from his neighbors that had the, it was about 10 miles away that had commercial, same variety, and his,
and had them tested for nutrient density and spectrum.
He was expecting maybe 50%, 70%, maybe 100% difference.
When he averaged it out, it was eight times, 800% different.
And not only that, but some elements like vitamin C were almost undetectable
in the commercial where he had huge levels. Many of the antioxidants, the polyphenols,
the flavonoids, very important micronutrients and stuff were many, many, many times what it was then he started to do taste tests he brought
people in and he said he'd learn really quickly that he first would give him a slice of the
commercial grown again exact same variety everything and everybody go oh yeah this is good
you know blah blah blah then he'd give him a sample of his grown and of course this is good, you know, blah, blah, blah. Then he'd give them a sample of his grown.
And of course, this is just the first year
of his getting a decent crop.
And so it'll only get better.
And people were just like blown away.
They couldn't even explain it.
It's like, wow, the flavor,
it's like exploding out of the top of my head i and and
it's lasting and it's so complex and it's just amazing and so you know all of a sudden we're
real you know he he's like we're on to something here and here's a guy that any any and he also
says you know i even had microbiology back in college.
And, you know, they basically learned that, you know, there are all these things in the soil and you got to kill them because they're pathogens.
He said, I never realized that most of them are beneficial.
And even insects, I was calling them pests.
You know, they're not really pests.
Pests don't want to eat my, they don't want to eat my crops if they're healthy.
They only want to eat them if they're not healthy.
He said, I never, in 40 years of this, I never learned this.
So, you know, that's the positive and the power of what we're learning of something as simple as, you know, we've been going in the wrong direction with the base of our growing of what we ingest to survive and be healthy.
And the magnitude of the problem is just, you know, mind blowing to us that always thought
there was some difference, but, you know, that's how extreme it is. And so that's where, and of course, the medical community,
that's where some people are starting to realize that and learn about that and where it just opens
up a whole new avenue of health. Because in regenerative agriculture now, we're able to
produce plants that are so healthy because we can understand nutrition to a deep level.
Soil health, microbiome to a deep level. They're resistant to all pests and all pathogens.
They might get a little hit a little bit, but not devastated. And now our livestock, we're doing the same by feeding
in those off of those plants. And we're getting the same result. And we realize,
why can't we get the same results with people? If we get them on this path and connect that science up. You know, why can't, you know, we may fall off our bike and break our arm.
But as far as all these diseases that have just exploded in the last 75 years, we think that we can, that's the way to solve these, you know.
So I guess that's how I'd explain it.
Definitely. you know so i guess that's how i'd explain it definitely there's such history to uh a lot of these different challenges um opportunities and also different approaches or uh different initiatives that are existing in the world and looking at things from the overall,
just like how different actions we might have taken as a society in the past to address
different acute situations, especially from an environmental perspective, is having this
real world implication today and how much of a difference it can make from even if we think we're eating
like one carrot equals one carrot, that may not always be true. And one of the points you were
making towards the beginning of what you were sharing just about how the foods that we're
eating don't have the same taste anymore, I think is a really relevant point. And whenever I'm talking to different,
especially European friends,
and then they come here and they make different dishes,
I feel like I've heard a lot of complaints recently
of how tomatoes don't taste the same at all.
And it completely transforms what they're trying to make from a cooking perspective,
let alone from that health perspective as well.
One curiosity that was popping into my mind as you were talking is,
like, there are so many different studies showing how the Mediterranean diet
is really this great diet that can help from a longevity,
different biomarker perspective,
but maybe an element there should really be looking at, okay, what does a tomato there equal
a tomato that might be available in other parts of the world, in the U.S., or in other kind of
nutrient depleted soil areas as well.
So I think there's a lot more opportunity within that domain.
So appreciate you sharing a bit more context there.
For anyone else who has joined in in the past couple minutes,
this is a space to share different updates from your project or any other projects you might know in the
ecosystem in the desize space of what you got done this week. If you're not able to speak, feel free
to leave a comment down below and we can read those off to share some of those updates too.
Also, if you have any upcoming events, would love to be in the know about those. One of the first
tweets pinned up above is also to the DSI event calendar. So if you have events now or sometime
way in the future, definitely submit those there. Everyone who's subscribed to that calendar is specifically looking for DSI events to attend, participate, or contribute to.
So please share or add those directly to the calendar and we can get those posted for everyone.
So if you have any updates, request the mic as we are approaching the top of the hour. Wanted to read off one update from
SpecTruth AI. So I'll just kind of read through this post. SpecTruth AI had a great week because
we did well on our preliminary meeting with the Ukraine Ministry of Health to open our clinic
and the construction of our facility is taking shape.
There's a short clip of standing in front of the building and it can be seen on their most recent
post. Also, thank you for joining in Spectruth AI. So the link to that post is down below in the comments as well if you want to take a look there.
I think one other thing that's been top of mind for me or seeing pop up a couple different places
is the situation with 23andMe filing bankruptcy and being open to be acquired by another organization and a couple different bids for engagement
being placed from SEI as well as some of the work that GenomesDAO has been doing for years
on giving people more ownership and also opening up to advanced research from a genetic data
perspective. So if you're not following those conversations,
would recommend checking out what's happening at GenomeStow,
as well as to follow along to see if Stay is able to get that bid on 23andMe.
I think this will be a really interesting example of what it might look like for some of these large companies, startups, to then possibly have an opportunity to move into a more decentralized state. for the world of just what level of interest and engagement from the
average person there is in terms of open source data or desire to engage with
some of their own data. And so that's one other kind of space or conversation I'm
following along as well. All right, not seeing any additional hands popping up so
if you're trying to request the mic I'm not able to see that come through. For
any of the speakers up here right now, DesaiAsia, PoseidonDao, Ed, any other
closing thoughts, things top of mind before we close out the space today.
You mentioned events calendar.
I think we were talking about that last week or something.
Where is that?
Is that in the cloud above or is that a DM or a community,
X DM group or is that a community group or what? Yeah, it's just on Luma, just shared it again.
So lu.ma slash musematrix,
try to keep it fairly updated with different events,
can be virtual, like different X spaces
or other like Zoom events as well
as in-person events so main things coming up in person to keep on your
radar an event tonight in San Francisco an event on Sunday at quantum bio doubt at QuantumBioDAO in LA, DSi London on April 12th and 13th.
So those are a few fun things that I'll at least be at.
So we'd love to see any of you there if you're in the area
or if you want an excuse to go to those areas as well.
Awesome. Well we'll be back here next week as well Wednesday at 12 p.m. Eastern
time with another kind of core theme topic to dive into. If you have a topic
maybe a new community initiative or something you're seeing happening in
DSci or the broader scientific as well as tech spaces, please reach out either
to the DSci Mike account or myself Erin. My profile's up here as well and we can get that
scheduled in and then come back next week Friday for the next episode of Desai
What Did You Get Done This Week covering some of these updates and other upcoming events just like
you're joining in now. So hopefully we'll see you back at those events or in person sometime soon.
Thanks so much everyone everyone, for tuning
Thank you, Erin. Thanks. Have a great weekend, everyone.
Yeah, everyone. And don't forget to apply the gg-tentive-free design community run.
Bye-bye.
